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The Toll-like receptor adaptor protein MyD88 is
essential for the regulation of intestinal homeostasis
in mammals. In this study, we determined that
Myd88-deficient mice are susceptible to colonic
damage that is induced by dextran sulfate sodium
(DSS) administration resulting from uncontrolled
dissemination of intestinal commensal bacteria. The
DSS-induced mortality of Myd88-deficient mice
was completely prevented by antibiotic treatment
to deplete commensal bacteria. By using cell type-
specific Myd88-deficient mice, we established that
B cell-intrinsic MyD88 signaling plays a central role
in the resistance to DSS-induced colonic damage
via the production of IgM and complement-mediated
control of intestinal bacteria. Our results indicate that
the lack of intact MyD88 signaling in B cells, coupled
with impaired epithelial integrity, enables commensal
bacteria to function as highly pathogenic organisms,
causing rapid host death.
INTRODUCTION
The gastrointestinal tract is the primary site of interactions
between the host tissue and the microbiota. Gut microbial
communities have a broad impact onmany aspects of host phys-
iology, including the immune system. Strong evidence supports
the hypothesis that eukaryotic hosts and their symbionts have co-
evolved toward mutualistic interactions, in which each partner
benefits from the association (Ba¨ckhed et al., 2005; Dethlefsen
et al., 2007). Homeostasis is achieved through multiple host
defense mechanisms that constantly manage commensal
bacteria via sophisticated mechanisms that rely on the activation
of the innate and adaptive immune systems (Hill and Artis, 2010;
Hooper and Macpherson, 2010; Saleh and Trinchieri, 2011). The
factors required for intestinal homeostasis include antibacterial
peptides expressed by epithelial cells (Ganz, 2003), mucus228 Immunity 36, 228–238, February 24, 2012 ª2012 Elsevier Inc.produced by goblet cells (Johansson et al., 2011), IgA secreted
by B cells (Hapfelmeier et al., 2010; Shang et al., 2008; Fagarasan
and Honjo, 2004), and pro- and anti-inflammatory cytokines ex-
pressed by NK and T cells (Cella et al., 2009; Littman and Ruden-
sky, 2010; Satoh-Takayama et al., 2008; Zenewicz et al., 2008).
Experiments with a DSS-induction model of colonic damage
showed that the activation of the adaptor protein MyD88 by IL-
18 and TLRs is critical for the regulation of intestinal homeostasis
(AbrahamandMedzhitov, 2011;Abreu, 2010;Asquith andPowrie,
2010; Rakoff-Nahoum et al., 2004; Saleh and Trinchieri, 2011).
Under steady-state conditions, the lackof TLRand IL-18 signaling
in Myd88-deficient mice is compensated for by other effector
mechanisms, such as the production of IgA (Slack et al., 2009),
but the induction of epithelial cell injury by treatment with dextran
sodium sulfate (DSS) leads to severe intestinal pathology and
rapid mortality in these mice (Rakoff-Nahoum et al., 2004).
Because MyD88 functions in multiple cell types downstream of
numerous TLRs and cytokines of the IL-1 family (Adachi et al.,
1998; Kawai et al., 1999), the cellular mechanisms underlying
MyD88-dependent host protection are unclear. Whereas MyD88
signaling in epithelial cells regulates cell proliferation and the
induction of antimicrobial peptides (Brandl et al., 2010; Brown
et al., 2007; Cash et al., 2006; Ismail et al., 2011), the activation
of the MyD88 signaling pathway in macrophages and dendritic
cells (DCs) regulates cell maturation and the secretion of proin-
flammatory cytokines (Hou et al., 2011a; Iwasaki and Medzhitov,
2010; Kelsall, 2008). Furthermore, MyD88 is indispensible for the
proper activation of both T andB cells (Ehlers et al., 2006;Gelman
et al., 2004; Hou et al., 2011b; Meyer-Bahlburg et al., 2007).
Because of the intrinsic complexity of MyD88 signaling in various
types of immune cells, we investigated the cell type-specific
requirement forMyD88 in the regulation of intestinal homeostasis.
We established that DSS-induced colon injury results in the lethal
dissemination of commensal bacteria in complete and B cell-
specificMyd88-deficientmice.At thesame time,MyD88signaling
in other cell typeswas largely dispensable for controlling intestinal
bacteria dissemination after DSS-induced intestinal damage. We
also identified IgM and complement as the key host protection
factors that are regulated by B cell-intrinsic MyD88 signaling
and identified IgAasanadditional factor that is involved in control-
ling intestinal bacteria after intestinal damage.
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Figure 1. Commensal Bacteria Are Responsible for the Mortality of Myd88-Deficient Mice
(A) WT andMyd88/ (Myd88 KO) mice received 2% DSS alone or 2% DSS+Abx (ampicillin + vancomycin + neomycin sulfate + metronidazole) in their drinking
water for the duration of the experiment. Mice were monitored for 60 days after the initiation of DSS treatment. The results shown are representative of nine
experiments, each of which included at least four mice per group.
(B) Myd88/ mice received 2% DSS+Abx for 30 days and were subsequently switched to drinking water containing DSS only. The results shown are repre-
sentative of three experiments, each of which included at least four mice per group.
(C)Myd88/mice (four mice per group) were left untreated (open bars), treated with Abx (black bars), treated with DSS (red bars), or treated with DSS+Abx (blue
bars) in their drinking water, as described in (A). The bacterial loads in the liver and lungs were analyzed on day 10 posttreatment by plating tissue lysates on blood
agar. Similar numbers of bacteria were detected under aerobic (shown here) and anaerobic (not shown) conditions. The results shown are representative of
four experiments, each of which included at least four mice per group.
(D) Serum levels of lactate dehydrogenase (LDH) and aspartate aminotransferase (AST) were analyzed in WT and Myd88/ mice on day 10 posttreatment.
The results shown are representative of three experiments.
*p < 0.01, **p < 0.001.
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Control of Commensals by MyD88 Signaling in B CellsRESULTS
Intestinal Commensal Bacteria Are the Cause of Death
in Mice Lacking MyD88 after DSS-Induced Colonic
Damage
Treatment of Myd88/ mice with DSS reveals that commensal
bacteria provide TLR- and IL-18-dependent signals, which are
required for epithelial cell proliferation and the production of
tissue-protective factors. These data suggest that the activation
of TLR by commensal bacteria is essential for intestinal homeo-
stasis (Rakoff-Nahoum et al., 2004). Surprisingly, we observed
that the depletion of commensal bacteria by antibiotic treatment
protected Myd88-deficient mice from DSS-induced mortality notonlyafterashort, 7-day treatmentwithDSS (FigureS1availableon-
line) but also when the mice were treated with DSS for the entire
duration of the experiments (Figure 1A). To further test whether
commensal bacteria are responsible for the mortality observed in
DSS-treatedMyd88/ mice, the antibiotics were withdrawn after
30daysof treatmentwithDSS.Weobserved that the reconstitution
of the microbiota in DSS-treatedMyd88-deficient mice resulted in
the rapid death of these animals (Figure 1B), which strongly
indicates that commensal bacteria cause the mortality of the
Myd88/ mice in response to DSS treatment. This hypothesis
was confirmed by the recovery of a large number of bacteria
from all of the examined tissues of DSS-treated Myd88/ mice
(Figure 1C and data not shown) and the dramatically elevatedImmunity 36, 228–238, February 24, 2012 ª2012 Elsevier Inc. 229
WT Myd88 KO
N
ai
ve
D
SS
D
SS
+A
bx
N
a
iv
e
 W
T
A
b
+
W
T
D
S
S
+
W
T
A
b
+
D
S
S
+
W
T
N
a
iv
e
 M
y
d
8
8
 K
O
A
b
+
M
y
d
8
8
 K
O
D
S
S
+
M
y
d
8
8
 K
O
A
b
+
D
S
S
+
M
y
d
8
8
 K
O
0.0
0.5
1.0
1.5
2.0
2.5
IL
-
1
2
p
4
0
 (
n
g
/m
l)
N
a
iv
e
 W
T
A
b
+
W
T
D
S
S
+
W
T
A
b
+
D
S
S
+
W
T
N
a
iv
e
 M
y
d
8
8
 K
O
A
b
+
M
y
d
8
8
 K
O
D
S
S
+
M
y
d
8
8
 K
O
A
b
+
D
S
S
+
M
y
d
8
8
 K
O
0.00
0.05
0.10
0.15
0.20
T
N
F
 
(
n
g
/
m
l)
N
a
iv
e
 W
T
A
b
+
W
T
D
S
S
+
W
T
A
b
+
D
S
S
+
W
T
N
a
iv
e
 M
y
d
8
8
 K
O
A
b
+
M
y
d
8
8
 K
O
D
S
S
+
M
y
d
8
8
 K
O
A
b
+
D
S
S
+
M
y
d
8
8
 K
O
0.0
0.5
1.0
1.5
IL
-
1
β
 (
n
g
/m
l)
B
A
*
*
* *
*
*
*
*
*
*
*
0
5
10
15
P
a
t
h
o
l
o
g
y
 
s
c
o
r
e
Myd88 KOWT
DSS DSS+Ab- DSS DSS+Ab-
control
DSS
DSS+Abx
Figure 2. The Presence of Commensal Bacteria Is Essential for Colon Damage and the Induction of Cytokines after DSS Treatment
(A) WT andMyd88/ mice were left untreated (top), treated with 2% DSS (middle), or treated with 2% DSS+Abx (ampicillin + vancomycin + neomycin sulfate +
metronidazole, bottom) in their drinking water. The histological changes in the colon were analyzed on day 10 posttreatment based on the following additive
scoring system. For crypt integrity: 0, normal; 1, irregular crypts; 2, mild crypt loss; 3, severe crypt loss; 4, complete crypt loss with intact epithelial cell layer; 5,
complete loss of crypts and surface epithelium (<10 crypt width); and 6, complete loss of crypts and surface epithelium (>10 crypt width). For infiltration of
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Figure 3. B Cell-SpecificMyD88 Signaling Protects
Mice from DSS-Induced Colitis
(A) WT mice (depicted in black), completeMyd88/ mice
(depicted in red), and mice with a cell type-specific dele-
tion of MyD88 in epithelial cells (Villin-Cre 3Myd88flox/flox,
depicted in purple), dendritic cells (CD11c-Cre 3
Myd88flox/flox, depicted in blue), epithelial cells and DCs
(Villin-Cre3CD11c-Cre3Myd88flox/flox, depicted in gray),
monocytes and macrophages (LysM-Cre 3 Myd88flox/flox,
depicted in orange), T cells (Lck-Cre 3 Myd88flox/flox, de-
picted in yellow), or B cells (CD19-Cre 3 Myd88flox/flox,
depicted in green) were treated with 2% DSS in their
drinking water and monitored for survival for 30 days.
(B) The histological changes in the colon were analyzed on
day 10 post-DSS treatment. The results are representative
of six experiments, each of which included between four
and six mice per group.
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Control of Commensals by MyD88 Signaling in B Cellsserumlevelsof tissuedamagemarkers in theseanimals (Figure1D).
These results suggest that despite the many beneficial effects of
commensal bacteria on host physiology, the lack of MyD88
enables microbiota to function as pathogenic bacteria that cause
mortality in these mice during DSS-induced colonic damage. We
also observed that antibiotic treatment not only prevented the
mortality of Myd88/ mice but also dramatically reduced the
inflammation and epithelial cell erosion caused by DSS treatment
(Figure 2A). Furthermore,we noted that the impairment of epithelial
cell integrity by DSS treatment provoked potent, commensal
bacteria-driven MyD88-dependent cytokine responses, similar to
those typically observed in response to pathogens (Figure 2B).
Taken together, our results suggest that the lack of a crucial
component of the TLR, IL-1, and IL-18 signaling cascade changesinflammatory cells into the mucosa: 0, normal; 1, mild; 2, modest; and 3, severe. For infiltration into th
For infiltration into themuscle: 0, normal; 1, mild; 2, modest; and 3, severe. The scores for each parame
Antibiotic treatment alone had no detectable effects on the architecture of WT or Myd88/ colons (
(B) IL-12p40, TNF, and IL-1b secretion from the colons isolated fromDSS- or DSS+Abx-treatedWT an
The results shown are representative of three experiments, each of which included at least four mice p
lumen in the histological images. *p < 0.01.
Immunity 36, 228the beneficial host-bacteria relationship into a
highly pathogenic relationship, which causes the
mortality ofMyd88/ mice after DSS treatment.
Because both TLRs and IL-1 family members
can activate MyD88 (Adachi et al., 1998; Kawai
et al., 1999), we assessed the relative contribu-
tion of these activators to host protection from
DSS-induced colonic damage. We evaluated
mice lacking all of the major TLRs involved in
bacterial recognition and established that the
cooperation between TLR9 and caspase-1
plays a major role in protecting the host from
commensal bacteria. Surprisingly, TLR2, TLR4,
and TLR5 were dispensable for resistance to
DSS-induced colonic damage (Figure S2).
B Cell-Intrinsic MyD88 Signaling Plays
aMajor Role in Host Protection after DSS-
Induced Colonic Damage
We addressed the question of how the cell-
specific activation of MyD88 regulates hostprotection from DSS-induced intestinal damage by investigating
a set of mice in which MyD88 is inactivated in a cell type-specific
manner. It is well established that TLR and IL-18 signaling in
epithelial cells plays a major role in the innate control of micro-
biota via multiple mechanisms, including the induction of antimi-
crobial peptides and the regulation of cell proliferation (Abreu,
2010; Brown et al., 2007; Cash et al., 2006; Dupaul-Chicoine
et al., 2010; Rakoff-Nahoum et al., 2004; Salcedo et al., 2010).
Nevertheless, we observed that the deletion of the Myd88flox
allele in epithelial cells, which was achieved by the expression
of Cre recombinase under the Villin promoter, had no detectable
effects on resistance to DSS-induced colitis (Figure 3A). Simi-
larly, despite the requirement for TLR signaling in DCs for the
regulation of innate and adaptive immunity (Iwasaki ande submucosa: 0, normal; 1, mild; 2, modest; and 3, severe.
ter were added, resulting in a total scoring range of 0 to 17.
not shown).
dMyd88/mice on day 10 after the initiation of treatment.
er group. A green asterisk indicates the position of the gut
–238, February 24, 2012 ª2012 Elsevier Inc. 231
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Figure 4. B Cell-Intrinsic MyD88 Signaling Restricts the Dissemination of Commensal Bacteria after DSS-Induced Colonic Damage
(A) Mice with a cell-specific deletion of MyD88 in epithelial cells, DCs,monocytes andmacrophages, T cells, and B cells and control animals were treated with 2%
DSS in their drinking water. Aerobic (left) and anaerobic (right) bacteria were recovered from the livers of the mice on day 10 post-DSS treatment. The colonies
were analyzed by plating the bacteria on blood agar. *p < 0.01.
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Control of Commensals by MyD88 Signaling in B CellsMedzhitov, 2010; Kelsall, 2008; Niess et al., 2005), a DC-specific
deletion of Myd88 only partially enhanced susceptibility to DSS
treatment. Moreover, mice in which Myd88 was depleted in
both DCs and epithelial cells were still relatively resistant to
DSS treatment (Figure 3A). These results suggest that MyD88
signaling in cell types other than DCs and epithelial cells is
required for host survival after DSS-induced colonic damage.
In an additional attempt to identify cells involved in MyD88-
dependent host protection against DSS-induced colonic injury,
we generated mice lacking MyD88 in macrophage lineages
(LysM-Cre 3 Myd88flox/flox, M-Myd88/) and in T (Lck-Cre 3
Myd88flox/flox, T-Myd88/) and B (CD19-Cre 3 Myd88flox/flox,
B-Myd88/) cells. We observed that the selective inactivation
of MyD88 in B cells rendered these mice highly susceptible to
DSS-induced colitis (Figure 3A). In contrast, the cell-specific
deletion of MyD88 in any other single cell type or a combined
MyD88 deficiency in DCs and macrophages (DC/M-Myd88/)
or in DCs and epithelial cells (DC/E-Myd88/) had limited
effects on the survival of DSS-treated mice (Figure 3A). Histolog-
ical analyses of the colon also revealed a major role for MyD88
signaling in B cells in the protection against DSS-induced colitis
(Figure 3B). Whereas intact MyD88 in DCs was required to limit
the severity of colitis, the lack of MyD88 signaling in macro-
phages and epithelial cells had no detectable effect on the resis-
tance to DSS-induced tissue damage (Figure 3B). A crucial role
for B cell-intrinsic MyD88 signaling in protecting the host from
DSS-induced colonic damage was further supported by the
observation that the adoptive transfer of WT B cells into
Myd88/ mice partially protected the recipients from DSS-
induced mortality. In contrast,Myd88/ B cells failed to protect
the mice in the same experiment (Figure S3A). Tlr9/ B cells
were also not capable of rescuing Myd88/ mice from DSS-
induced mortality, suggesting that MyD88 activation triggered
by TLR9 is required for B cell-mediated host protection after
DSS-induced colonic damage (Figure S3A). An essential role
for B cells in the resistance to DSS treatment was also observed
in a mouse model in which the Jh gene has been deleted and
mature B lymphocytes are therefore absent (Figure S3B).
B Cell-Intrinsic MyD88 Signaling Restricts the
Dissemination of Commensal Bacteria during DSS-
Induced Colon Damage
Similar to the result observed in completeMyd88-deficient mice,
a large number of live bacteria were recovered under aerobic and
anaerobic conditions from the liver, lung, and other examined
tissues of B cell-specific Myd88-deficient mice (Figure 4A and
data not shown). On average, approximately 107 colonies were
recovered from each liver or lung from mice lacking MyD88 in
all cell types. High, but still reduced, bacterial loads were de-
tected in the tissues of B cell-specific Myd88-deficient mice.
All of the other examined cell type-specificMyd88 gene-targeted
mice were statistically indistinguishable from the WT controls(B) The dissemination of bacteria in the livers of WT mice and of mice lacking M
deficient mice on day 10 post-DSS treatment by in situ hybridization. Yellow arro
samemice after H&E staining is shown below the in situ hybridization images. The
four mice per group, and the images shown are representative of multiple sectio
(C) Bacterial DNA was isolated from the livers ofMyd88/ (left) and B-Myd88/
analyzed by 16S RNA sequencing (blue, Firmicutes; green, Bacteroidetes; red, Pwith respect to the bacterial loads detected in the tissues exam-
ined (Figure 4A and data not shown). These results strongly
suggest that MyD88 signaling in B cells plays an integral role in
preventing the dissemination of commensal bacteria after
colonic damage. Becausemany commensal gut bacteria cannot
be grown under standard culturing techniques (Garrett et al.,
2010; Ley et al., 2008), we also applied a non-culture-based
method for the visualization and identification of commensal
bacteria. We visualized commensal bacteria by in situ hybridiza-
tion to their 16S RNA sequences, confirming the presence of
bacteria in the livers of DSS-treated Myd88/ and B-Myd88/
mice, but not in the other examined cell-specific Myd88-defi-
cient animals (Figure 4B). Additionally, sequencing analysis iden-
tified Firmicutes as a dominant phylogenetic group in the livers of
the DSS-treated Myd88/ and B-Myd88/ mice (Figure 4C).
The reduced numbers of bacteria observed in B cell-specific
Myd88-deficient mice compared with complete Myd88/
mice suggest that B cell-intrinsic MyD88 plays a major role in
controlling host resistance to DSS treatment, whereas MyD88
signaling in cells other than B cells is also involved in controlling
intestinal bacteria and in preventing their dissemination into
peripheral tissues. This model is also supported by the higher
degree of liver damage observed in complete Myd88/ mice
compared to B cell-specific Myd88-deficient mice (Figure 4B).
Nevertheless, it is important to note that commensal bacteria
were not detected in the livers ofmice lackingMyD88 in epithelial
cells, DCs, macrophages, or T cells, all of which have an intact
MyD88 signaling pathway in B cells (Figure 4 and data not
shown). Taken together, these results indicate that MyD88
signaling in B cells but not in epithelial cell or DC restricts the
dissemination of commensal bacteria during DSS-induced colon
damage.
A Role for IgM and IgA in the Protection against DSS-
Induced Colonic Damage
One well-characterized function of TLR signaling is the regula-
tion of antibody production in B cells (Ehlers et al., 2006; Hou
et al., 2011b; Shang et al., 2008; Shlomchik, 2009). In the context
of intestinal homeostasis, IgA is known to play a central role in
restraining commensal bacteria (Baker et al., 2010; Fagarasan
et al., 2010; Macpherson et al., 2008). Contrary to our expecta-
tions, we observed that a B cell-specific deletion of Myd88 had
little effect on commensal bacteria-specific IgA production, as
measured by a flow cytometric approach (Figure S4). Further-
more, the analysis of total IgA levels by ELISA and immunohisto-
chemical methods failed to reveal a B cell-intrinsic role for
MyD88 in the regulation of IgA production. This contrasts with
the substantially reduced titers of commensal bacteria-specific
IgA that was observed in complete Myd88/ mice (Figure S4).
Moreover, the flow cytometry-based quantification of IgA-posi-
tive cells in the lamina propria and Peyer’s patches of naive
and DSS-treated Myd88/ mice strongly suggested thatyD88 in all tissues was analyzed compared to the cell type-specific Myd88-
ws point to the detected bacteria. Histopathological analysis of livers from the
results shown are representative of at least four experiments including three or
ns examined.
(right) mice, and the relative frequencies of the major phylogenetic groups were
roteobacteria; yellow, Deferribacteres; and black, Actinobacteria).
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Figure 5. B Cell-Intrinsic MyD88 Signaling Regulates Complement-Mediated Host Protection from Commensal Bacteria during Colonic
Damage
(A and B) The IgM levels in the stools of naive and DSS-treated WT, Myd88/, and B-Myd88/ mice were measured by (A) ELISA or (B) flow cytometry. The
experiment shown is representative of three experiments, each of which included at least four mice per group. The black bars and histograms depict WT mice,
and the red and blue bars and histograms depict B cell-specific and complete Myd88/ mice, respectively.
(C) IgM secretion by purified WT andMyd88/ B cells stimulated with commensal bacterial extract (10 mg/ml) for 72 hr. IgM levels in the cell culture supernatant
were measured by ELISA. The results shown are representative of three experiments. ***p < 0.0001.
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Immunity
Control of Commensals by MyD88 Signaling in B Cellsalthough MyD88 signaling regulates IgA production by B cells,
intact MyD88 in cell types other than B cells is required for this
process (Figure S5).
In search of a B cell-intrinsic role for MyD88 in the regulation of
protection from intestinal bacteria, we analyzed IgM production
in the colons of naive and DSS-treated mice. We focused on
this immunoglobulin isotype because, in addition to IgA, large
quantities of IgM are present in mucosal tissues (Cerutti et al.,
2011; Johansen et al., 2000). No differences in the levels of
IgM were observed between WT and any of the examined
MyD88-deficientmice under steady-state conditions (Figure 5A).
In contrast, the lack ofMyD88 resulted in decreased levels of IgM
in the lumen of DSS-treated mice, and the B cell-restricted
deletion of Myd88 partially recapitulated the IgM deficiency
observed in the complete Myd88/ mice (Figure 5A). Flow
cytometry revealed that whereas a large fraction of intestinal
bacteria were coated with IgM in WT mice, the loss of MyD88
specifically in B cells dramatically reduced IgM-coated
commensal bacteria (Figure 5B). This result suggests that B
cell-intrinsic MyD88 signaling is essential for the IgM-mediated
control of commensal bacteria (Figure 5B).
Although we observed no difference in the frequencies of
IgM-positive B cells in the lamina propria and Payer’s patches
of naive and DSS-treated B-Myd88/ mice (Figures S5C and
S5D), intact MyD88 was essential for IgM secretion in response
to commensal bacteria (Figures 5C and S5E). A comparative
analysis of IgA secretion under the same conditions revealed
a partial requirement for MyD88 in the regulation of IgA secretion
(Figure S5F). Finally, we directly examined the susceptibility of
IgM- and IgA-deficient mice to DSS treatment. We observed
rapid mortality of IgM- and IgA-deficient mice in response
to DSS treatment (Figure S6), which closely resembled the
susceptibility of B-Myd88/ mice.
Taken together, our results suggest that B cell-intrinsic MyD88
signaling regulates IgM-mediated host protection. In addition,
B cells provide IgA-mediated resistance to DSS treatment that
depends in part on intact MyD88 signaling.
A Role for Complement in the Protection against
DSS-Induced Colonic Damage
Antibodies mediate protection via multiple mechanisms, such
as activating the classical complement system, facilitating the
uptake of opsonized bacteria for rapid killing by macrophages,
and enhancing the production of proinflammatory cytokines
(Cerutti et al., 2011). IgM is considered to be a poor opsonin,
but it is a potent activator of the complement system (Carroll,
1998). We observed that in WT mice, epithelial cells and
commensal bacteria were segregated by the deposition of
complement factor C3, whichwas not observed in B cell-specific
or complete Myd88 gene-targeted mice (Figure 5D). Further-
more, a significant fraction of luminal bacteria were coated(D) Complement deposition in the colons of WT, Myd88/, and B-Myd88/ mi
(E) The percentages of commensal bacteria covered with C3 (green curves) we
experiment shown is representative of three experiments, each of which include
(F)WT,Myd88/, and B-Myd88/micewere left untreated (naive), treatedwith 2
were analyzed on day 10 posttreatment. The results shown are representative o
(G and H) The survival (G) and the dissemination (H) of commensal bacteria in th
post-DSS or DSS+Abx treatment. The experiment shown is representative of fouwith factor C3 in WT mice but not in Myd88/ or B-Myd88/
mice (Figure 5E). Although DSS treatment resulted in the
commensal bacteria- and MyD88-dependent upregulation of
C3 production, a lack of MyD88 in only B cells had no effect
on the induction of C3 in response to DSS treatment (Figure 5F).
Thus, it is likely that B cell-intrinsic MyD88 is essential for C3
activation rather than C3 production. These data, combined
with the observation that commensal bacteria-specific IgM is
reduced in B-Myd88/ mice, suggest that B cell-intrinsic
MyD88 is essential for IgM-mediated deposition of complement
factor C3 on commensal bacteria.
To investigate the relevance of this observation to host pro-
tection after DSS treatment, we investigated the survival of
C3/ mice during colonic damage. We found that C3-deficient
mice succumbed to DSS treatment very rapidly, and these mice
had essentially the same mortality kinetics as did Myd88/
mice (Figure 5G). Furthermore, we observed that the lack of
C3 resulted in the dissemination of commensal bacteria to the
peripheral tissue at levels comparable to those observed in
mice lacking the TLR adaptor protein (Figure 5H). Importantly,
the antibiotic-mediated depletion of intestinal bacteria protected
C3/ mice from DSS-induced mortality (Figure 5G). These
results revealed an essential role for the complement system
in controlling intestinal homeostasis during colonic damage via
the restriction of the dissemination of commensal bacteria.
DISCUSSION
Intestinal commensal bacteria communicate continuously with
host epithelial and innate and adaptive immune cells under
both steady-state and stressful conditions (Hooper and Mac-
pherson, 2010; Lee and Mazmanian, 2010; Ley et al., 2008).
These interactions have abundant beneficial effects on host
metabolism and immune function. However, these interactions
require host factors for the maintenance of immune homeo-
stasis. The oral administration of DSS, which is directly toxic
to enterocytes, has been a crucial tool for the identification of
the cell signaling pathways involved in the regulation of host-
commensal bacteria interactions (Saleh and Trinchieri, 2011).
Among these factors, the TLR and IL-1 family receptor signaling
adaptor protein MyD88 plays a central role in resistance to
experimental DSS-induced colitis. Myd88/ mice, which
cannot signal through IL-1 family receptors or most TLRs, are
acutely susceptible to DSS-induced colonic injury (Rakoff-
Nahoum et al., 2004). It appears that both TLR-dependent and
IL-18-dependent activation of MyD88 are essential for host
resistance to DSS-induced colonic damage (Dupaul-Chicoine
et al., 2010; Rakoff-Nahoum et al., 2004; Salcedo et al., 2010;
Saleh and Trinchieri, 2011; Zaki et al., 2010).
Our results in mice simultaneously lacking multiple TLRs that
are involved in bacterial recognition suggested that TLR9- andce treated with DSS was visualized by anti-C3 staining.
re analyzed by flow cytometry. Black curves represent isotype controls. The
d at least four mice per group.
%DSS, or treatedwith 2%DSS+Abx in their drinking water. Serum levels of C3
f three experiments.
e livers and lungs of WT, Myd88/, and C3/ mice were analyzed on day 10
r experiments, each of which included at least four mice per group.
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host resistance to DSS-induced colonic damage. We also deter-
mined that MyD88 signaling in B cells is required to control
commensal bacteria after intestinal damage. Our results high-
lighted the physiological importance of TLR signaling in B cells
for IgM- and complement-mediated host protection after
DSS-induced colonic damage.
It is well known that the lack of MyD88 in all cell types results in
rapid mortality after DSS treatment in mice (Abraham andMedz-
hitov, 2011; Saleh and Elson, 2011). Based on the results of
previous studies, this outcome can be attributed to the deregu-
lated epithelial cell homeostasis that is a result of the impaired
recognition of commensal bacteria by the cells. The intestinal
epithelium provides not only a physical barrier against the exces-
sive entry of luminal microbiota but also executes the MyD88-
dependent microbe sensing programs that are required for the
restriction of intestinal bacteria via the production of antimicro-
bial peptides and epithelial cell proliferation (Hooper and Mac-
pherson, 2010). Surprisingly, the lack of MyD88 in epithelial cells
had no effect on the survival of mice after DSS treatment.
Furthermore, colonic damage was comparable between epithe-
lial cell-specificMyd88-deficient mice (Villin-Cre3Myd88flox/flox)
and their WT counterparts (Myd88flox/flox mice without Cre
expression or Villin-Cre 3 Myd88flox/wt mice).
We observed that the uncontrolled dissemination of
commensal bacteria was responsible for the mortality of
Myd88/mice during prolonged DSS-induced colonic damage.
The depletion of commensal bacteria by antibiotic treatment
during DSS-induced colonic damage completely rescued
Myd88/ mice from the mortality that typically occurs in DSS-
treated mice. Furthermore, reconstitution of the intestinal micro-
biota in DSS-treated Myd88/ mice reverted their resistance
and resulted in the mortality that is associated with the dissem-
ination of commensal bacteria throughout the peripheral tissues.
These results formally demonstrated thatMyD88 is indispensible
in restricting intestinal bacteria from invasion and dissemination
when the integrity of the epithelial cell layer is compromised. In
our attempts to identify the cell-specific requirements for
MyD88 signaling, we observed that whereas TLR signaling in
DCs and macrophages contributed to host protection, B cell-
intrinsic MyD88 played the most critical role in orchestrating
host protection after DSS-induced colonic injury. Although
MyD88 activation has multiple cell-specific downstream effects,
our results suggested that B cell-intrinsic MyD88 signaling is
required to coordinate the IgM- and complement-mediated
control of intestinal bacteria after DSS-induced colonic damage.
Because the fraction of intestinal bacteria that was coatedwith
IgM and complement C3 fragments was substantially decreased
by the deletion of MyD88 in B cells, it is likely that the key protec-
tive function of MyD88 in B cells is to promote the production of
IgM antibodies that subsequently bind to commensal organ-
isms. This function is essential for preventing bacteria from gain-
ing access to the subepithelial tissue after DSS-induced
breaches of the epithelial barrier.
Our work also revealed an important role for IgA in conferring
protection against DSS-induced colitis. However, IgA responses
were only partially regulated by MyD88, and it is likely that TLR,
IL-1R, and IL-18R signaling in cell types other than B cells is
involved in the regulation of commensal bacteria-specific IgA236 Immunity 36, 228–238, February 24, 2012 ª2012 Elsevier Inc.responses. In addition, because mutations in the antigen-
binding variable region of IgA are crucial for the control of
commensal bacteria, further studies will be needed to investi-
gate whether B cell-intrinsic or -extrinsic MyD88 signaling is
involved in somatic hypermutation (Wei et al., 2011). Our exper-
iments cannot rule out the possibility that the lack of B cell-
intrinsic MyD88 reduces protection against colitis by impairing
the induction of somatic hypermutations.
Although the mechanism we identified does not exclude
additional functions for TLR signaling in B cells and other innate
and adaptive immune cells, our work does emphasize the
importance of B cell-intrinsicMyD88 in the regulation of intestinal
homeostasis via the restriction of commensal bacteria from
dissemination into the peripheral tissues. Our results suggest
that impaired MyD88-dependent recognition of commensal
bacteria causes normal microbiota to function as pathogenic
microorganisms and induces mortality in the mammalian host
when the barrier function of the epithelial layer is compromised.
EXPERIMENTAL PROCEDURES
Animals
C57BL/6 mice were obtained from the University of Texas Southwestern
(UTSW) Medical Center Mouse Breeding Core Facility. Tlr2/, Tlr4/,
Tlr9/, Myd88/, and Caspase-1/ mice were generously provided by
S. Akira and R. Flavell. Tlr5/ and Ighm/ (Ighmtm1Cgn) mice were obtained
from Jackson Laboratory. Igha/ and Jh/ mice were a gift from L. Hooper.
Myd88flox mice (B6.129P2-Myd88tm1Defr) and Myd88flox/flox 3 CD11c-Cre
(DC-Myd88/) mice have been described previously (Hou et al., 2008,
2011a). In this study, the Myd88flox mice were additionally crossed to Villin-
Cre (Madison et al., 2002), CD19-Cre (Rickert et al., 1997), LysM-Cre (Clausen
et al., 1999), CD11c-Cre 3 Villin-Cre, LysM-Cre 3 CD11c-Cre, and Lck-Cre
deleter mice, which were obtained from Jackson Laboratory. Control and
experimental mice were age matched within individual experiments.
All mice were maintained at the American Association of Laboratory Animal
Care-accredited animal facility at the UTSWMedical Center. All of the animals
that were used were age and sex matched and were maintained in the same
animal room. All experiments were performed with protocols approved by
the Institutional Animal Care and Use Committees of the UT Southwestern
Medical Center.
DSS and Antibiotic Treatment
Mice were treated with 2% (w/v) DSS (M.W. = 36,000–50,000 Da; MP Biomed-
icals) in their drinking water for the duration of the experiments. In the experi-
ments shown in Figure S1, the mice were treated with DSS for 7 days and
subsequently switched to regular drinking water. To deplete the gut
commensal microflora, WT, Myd88/, or cell type-specific Myd88-deficient
mice were treated with ampicillin (1 g/l), vancomycin (500 mg/l), neomycin
sulfate (1 g/l), and metronidazole (1 g/l) along with 2% DSS in their drinking
water. The efficiency of commensal bacteria depletion was verified by bacte-
riological analysis of the feces, which was performed by cultivating aerobic
and anaerobic bacteria on blood agar. Control animals were treated with
regular water or antibiotics alone without DSS. No mortality of Myd88/,
WT, or any cell type-specific Myd88-deficient mice was observed under the
control conditions. As indicated in Figure S3, in some experiments, DSS-
treated Myd88/ mice also received 2 3 106 purified WT B cells that had
been isolated from the spleens of naive WT, Myd88/, or Tlr9/ mice with
the Miltenyi B Cell Isolation Kit.
Histopathology and In Situ Hybridization
Mice were left untreated or were treated with 2% (w/v) DSS in their drinking
water for 10 days and subsequently necropsied. Portions of the colon and liver
were fixed in Bouin’s fixative, embedded in paraffin, cut into 5 mm sections,
and stained with hematoxylin and eosin (H&E). For in situ hybridization, the
livers were fixed in Carnoy’s fixative solution instead of Bouin’s fixative. After
Immunity
Control of Commensals by MyD88 Signaling in B Cellsdeparaffinization and rehydration in hybridization buffer (0.9 M NaCl, 0.1%
SDS, and 20 mM Tris-HCl [pH 7.4]), the colon and liver sections were incu-
bated overnight at 50C in the dark with an Alexa-488-conjugated EUB338
general bacterial probe for a bacterial 16S rRNA gene (50-GCT GCC TCC
CGT AGG AGT-30), which was diluted to a final concentration of 1 ng/ml in
hybridization solution. The sections were then washed three times with hybrid-
ization solution for 15 min, counterstained with SYTO62, and mounted with
ProLong Gold Antifade reagent (Invitrogen). The sections were imaged with
a Leica SPE system fitted with a Leica 633 objective NA 1.4. The data sets
were processed with Leica Advanced Fluorescence software (Leica).
Histological changes were analyzed in a double-blind fashion. The severity
of intestinal pathology was analyzed based on the following additive scoring
system. For crypt integrity: 0, normal; 1, irregular crypts; 2, mild crypt loss;
3, severe crypt loss; 4, complete crypt loss with an intact epithelial cell layer;
5, complete loss of crypts and surface epithelium (<10 crypt width); and
6, complete loss of crypts and surface epithelium (>10 crypts). For infiltration
of inflammatory cells into the mucosa: 0, normal; 1, mild; 2, modest; and
3, severe. For infiltration of the submucosa: 0, normal; 1, mild; 2, modest;
and 3, severe. For infiltration of the muscle: 0, normal; 1, mild; 2, modest;
and 3, severe. These scores were added, resulting in a total scoring range of
0 to 17.
Bacterial Cultures
To detect anaerobic and aerobic bacterial colonies in the liver and lung
tissues during DSS treatment, these organs were removed on day 10
post-DSS treatment, placed into 15 ml conical tubes with PBS, and homog-
enized. Aerobic bacteria were grown on LB agar or blood agar. Anaerobic
bacteria were grown on blood agar with an anaerobic vented jar (BD Biosci-
ences). Culturable bacteria counts were obtained by plating serial dilutions of
bacteria on the corresponding media for 48 hr (aerobes) or 72 hr (anaerobes)
(Benson et al., 2009). In some cases, bacterial genomic DNA was extracted
from the livers of DSS-treated Myd88/ and B-Myd88/ mice on day 10
posttreatment with the QIAGEN DNeasy kit according to the manufacturer’s
instructions. Broad-range 16S rDNA PCR (forward primer: 50-AGAGTTTGA
TYMTGGCTCAG-30 and reverse primer: 50-ACGGYTACCTTGTTACGACTT-
30) was used to amplify and clone the bacterial DNA present in individual
samples without any prior cultivation. To minimize contamination, all extrac-
tions and PCR amplifications were prepared with sterile solutions and filter
tips. Cloned inserts were identified through sequencing of the 16S rDNA
gene fragments with the pCR2.1 vector-specific M13 reverse and T7
promoter primers. The DNA sequences were interpreted by comparing the
retrieved sequences with those stored in the GenBank Data System with
the basic local alignment software tool (BLAST; National Center for Biotech-
nology Information) and the Seqmatch tool (Ribosomal Database Project).
Flow Cytometry and ELISA
Fecal pellets were disrupted in PBS by vortexing for 5 min, and insoluble
material was removed by filtering through a 100 mm filter (Millipore). The
bacteria were washed twice in PBS/5 mMEDTA/2% FBS before resuspension
in Alexa 488-conjugated anti-IgA or anti-IgM monoclonal antibodies (BD
PharMingen). Commensal bacteria-specific IgA and IgM were assessed by
staining luminal bacteria for 30 min on ice. The data were acquired with
a FACSCalibur cytometer (BD PharMingen) and were analyzed with FlowJo
software (TreeStar). The total IgA and IgM levels in the fecal extracts were
assessed by ELISA (Bethyl Laboratories) according to the manufacturer’s
instructions.
To assay cytokine responses in mice treated with DSS, colons were har-
vested from the mice on day 7 or 10 posttreatment, extensively washed with
PBS, cut longitudinally, and incubated overnight in cell culture media
(RPMI+10% FBS). The IL-12p40, TNF, IL-1b, and IL-6 concentrations in the
supernatants were determined with ELISA kits from eBioscience according
to the manufacturer’s instructions.
Statistical Analysis
All data were analyzed with Prism (Version 5; GraphPad). The data were
considered statistically significant when p values were less than 0.05 by
a two-tailed t test.SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and can be found with this
article online at doi:10.1016/j.immuni.2011.11.019.
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